Correction: Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-02-12
DOI
https://doi.org/10.3389/fphar.2026.1788169
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin

Wei Cheng, Jing Qian, Di Gao, Li Deng et al.
Frontiers in Pharmacology
Lung Cancer Treatments and Mutations
article

Correction: Network pharmacology, bioinformatics and in vitro/in vivo validation elucidate the anti-lung cancer activities and potential targets of Rhoifolin

Wei Cheng, Jing Qian, Di Gao, Li Deng, Yunhui Zhang
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 17
Qingdao University (CN), Southwest University (CN), First People's Hospital of Yunnan Province (CN), 81th Hospital of PLA (CN)
Openalex Percentile: Top 60%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.